Disease: Acute Antibody-mediated Rejection
- A gentler approach to monitor for heart transplant rejection
- A heart transplant center experience with basiliximab induction strategies: A double edged sword?
- A modified perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy
- A Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation
- ABO Incompatible Kidney Transplantation Without B-cell Depletion is Associated With Increased Early Acute Rejection: A Single-Center Australian Experience
- ABO Incompatible Living Donor Liver Transplantation in Children: A Single Centre Experience from India
- ABO-incompatible living donor kidney transplantation failure due to acute blood group antibody-dependent rejection triggered by human parvovirus B19 infection: a case report and literature review
- ABO-Incompatible Orthotopic Liver Transplant as a Rescue Strategy for Fulminant Hepatic Failure in a Recipient With Breast Cancer: Highlights on Transplant Management
- Acute rejection post lung transplant
- Antibody-mediated rejection in xenotransplantation: Can it be prevented or reversed?
- Antibody-mediated rejection with detection of de novo donor-specific anti-human leukocyte antigen Class II antibodies after lung transplantation: Problems in diagnosis, treatment and monitoring on a case report basis
- Assessing the role of phosphorylated S6 ribosomal protein in the pathological diagnosis of pulmonary antibody-mediated rejection
- Association between blood transfusion after kidney transplantation and risk for the development of de novo HLA donor-specific antibodies and poor clinical outcomes: A single-center retrospective study
- B Cell-mediated Immune Regulation and the Quest for Transplantation Tolerance
- Banff 2022 pancreas transplantation multidisciplinary report: Refinement of guidelines for T cell-mediated rejection, antibody-mediated rejection and islet pathology. Assessment of duodenal cuff biopsies and noninvasive diagnostic methods
- Blood group-specific apheresis in combination with daratumumab as a rescue therapy of acute antibody-mediated rejection in a case of ABO- and human leukocyte antigen-incompatible kidney transplantation
- C1 esterase inhibitor-mediated immunosuppression in COVID-19: Friend or foe?
- Cardiac Allograft Rejection: Strategies for Success in the Face of Immune Challenges
- Chronic Active Antibody-mediated Rejection: Opportunity to Determine the Role of Interleukin-6 Blockade
- Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation
- Clinical and Histopathologic Characteristics of Recurrent Sarcoidosis in Posttransplant Lungs: 25 Years of Experience
- Color Doppler Guided in Early Renal Allograft Biopsy: A Safer and Non-Inferior Technique
- Consideration for alpha-gal syndrome in two critically ill persons with group O blood who received group B plasma
- Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future
- Current Therapies in Kidney Transplant Rejection
- De novo Donor-specific Anti-human Leukocyte Antigen Antibody and Its Outcome in Pediatric Renal Transplant Recipients: A Single-center Experience in India
- Diagnostic accuracy of brain natriuretic peptide and N-terminal-pro brain natriuretic peptide to detect complications of cardiac transplantation in adults: A systematic review and meta-analysis
- Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy
- Distinct Molecular Processes Mediate Donor-derived Cell-free DNA Release From Kidney Transplants in Different Disease States
- Donor-Derived Cell-Free DNA at 1 Month after Kidney Transplantation Relates to HLA Class II Eplet Mismatch Load
- Dual Antibody Treatment for Simultaneous Acute Cellular Rejection and Antibody-Mediated Rejection After Liver Transplantation: A Case Report
- Early conversion to belatacept-based immunosuppression regimen promotes improved long-term renal graft function in kidney transplant recipients
- Early Cytomegalovirus Reactivation in Renal Recipients Is Associated with High Levels of B Cell Maturation Antigen Transcript Expression Prior to Transplantation
- Early Versus Late Acute AMR in Kidney Transplant Recipients-A Comparison of Treatment Approaches and Outcomes From the ANZDATA Registry
- Efficacy of mTOR Inhibitors and Intravenous Immunoglobulin for Treatment of Polyoma BK Nephropathy in Kidney Transplant Recipients: A Biopsy-Proven Study
- Emerging phenotypes in kidney transplant rejection
- Eosinophilic infiltration as the initial trace of acute mixed cellular and antibody mediated rejection in a heart transplant patient with concomitant immense epitope-associated HLA-antibody production: a case report
- Evaluating threshold for donor fraction cell-free DNA using clinically available assay for rejection in pediatric and adult heart transplantation
- Evaluation of serial monitoring of donor-specific antibodies in pediatric and adult intestinal/multivisceral transplant recipients
- Exploration of the shared gene signatures and biological mechanisms between ischemia-reperfusion injury and antibody-mediated rejection in renal transplantation
- Feasibility of Interleukin-6 Receptor Blockade in Cardiac Antibody-mediated Rejection
- Heart Transplantation
- Heart transplantation and anti-HLA antibodY: myocardial dysfunction and prognosis - HeartLAy study
- Herpetic Keratitis Following Treatment of Acute Antibody-Mediated Rejection in a Renal Transplantation Recipient
- Histopathology, mRNA expression profile, and donor-derived cell-free DNA for assessment of rejection in pediatric heart transplantation
- Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival
- Immune landscape in rejection of renal transplantation revealed by high-throughput single-cell RNA sequencing
- Immune landscape of the kidney allograft in response to rejection
- Immunoglobulin A Deposits In Renal Allografts: A Prospective Longitudinal Single-Center Study
- Immunosuppression regimen modification during COVID-19 infection in kidney transplant recipients
- Impact of Preformed Donor-Specific Anti-HLA-Cw and Anti-HLA-DP Antibodies on Acute Antibody-Mediated Rejection in Kidney Transplantation
- Incidence and Role of Recipient-Specific Antibodies in Allogeneic Hematopoietic Cell Transplantation from Mismatched Related Donors
- Indoleamine 2,3-Dioxygenase 1 (IDO1) in Kidney Transplantation: A Guardian against Rejection
- Is M30 staining a reliable marker predicting graft rejection and fibrosis in protocolar liver biopsies in post-liver transplant pediatric patients?
- Kidney transplant outcomes in patients with antibodies to human neutrophil antigen 3a
- Long-term outcomes following ABO-incompatible living donor liver transplantation for acute liver failure: a single-center experience of over 20 years
- Longitudinal Change and Predictors of Myocardial Flow Reserve by Positron Emission Tomography for the Evaluation of Cardiac Allograft Vasculopathy Following Heart Transplantation
- Low-MFI (median fluorescence intensity) pre-transplant DSA (donor specific antibodies) leading to anamnestic antibody mediated rejection in live-related donor kidney transplantation
- Lowering maintenance immune suppression in elderly kidney transplant recipients; connecting the immunological and clinical dots
- Medium-term Outcomes in Pediatric Heart Transplant Recipients Managed Using a Steroid Avoidance Immune Suppression Protocol
- Mesangiolysis in Chronic Active Antibody-mediated Rejection in Kidney Transplant Biopsies
- Mesangiolysis in Pathological Chronic Active Antibody-Mediated Rejection in Kidney Transplant Biopsies
- Monitoring of plasma circulating donor DNA reflects cardiac graft injury: Report of two cases
- Myeloperoxidase Staining Identifies Endothelial Injury of Peritubular Capillaries and Glomeruli in Renal Antibody-Mediated Rejection
- Novel factors potentially initiating acute antibody-mediated rejection in pig kidney xenografts despite an efficient immunosuppressive regimen
- Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection
- Overcoming the Boundaries of Heart Warm Ischemia in Donation After Circulatory Death: The Padua Case
- Pediatric Acute Liver Failure Secondary to Autoimmune Hepatitis in an Infant With Thrombocytopenia-Absent Radius (TAR) Syndrome: A Case Report
- Performance and Advancement of the Kidney Solid Organ Response Test
- Plasma miR-150-5p in Renal Transplant Recipients with Acute Antibody-Mediated Rejection
- Predictors of graft failure after first detection of de novo donor-specific HLA antibodies in kidney transplant recipients
- Preemptive immune globulin therapy in sensitized lung transplant recipients
- Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators
- Recovery from antibody-mediated biliary ductopenia and multiorgan inflammation after COVID-19 vaccination
- Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival
- Relationship Between Donor Derived Cell-Free DNA and Tissue-Based Rejection-Related Transcripts In Heart Transplantation
- Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation
- Rituximab administration one week before ABO-incompatible liver transplantation due to drug-induced acute liver failure with hepatic coma: a case report
- Role of HLA matching and donor specific antibody development in long-term survival, acute rejection and cardiac allograft vasculopathy
- Roles of interferon regulatory factor 4 in the AKI-CKD transition, glomerular diseases and kidney allograft rejection
- Selection and Interpretation of Molecular Diagnostics in Heart Transplantation
- Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT)
- Strategies for ABO Incompatible Liver Transplantation
- Suspicious of Acute Kidney Graft Rejection: Tacrolimus Pharmacokinetics Under Methylprednisolone Therapy
- Tacrolimus After rATG and Infliximab Induction Immunosuppression-RIMINI Trial
- The Chronology of Renal Allograft Dysfunction: The Pathological Perspectives
- The curious case of T-cell mediated renal allograft rejection after Covid-19 infection
- The First Collective Examination of Immunosuppressive Practices Among American Intestinal Transplant Centers
- The incidence and role of recipient-specific antibodies (RSA) in allogeneic hematopoietic cell transplantation from mismatched related donors
- The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks
- The Molecular Phenotype of Kidney Transplants: Insights From the MMDx Project
- The Renal Histopathological Findings in Patients with Renal Allograft Dysfunction: A Retrospective Single Center Study
- The Transplant Bellwether: Endothelial Cells in Antibody-Mediated Rejection
- Three-year outcomes of de novo tacrolimus extended-release tablets (LCPT) compared to twice-daily tacrolimus in adult heart transplantation
- Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology
- Tissue Expression of Programmed Cell Death 1 Ligand1 (PD-L1) in Biopsies of Transplant Livers of Pediatric Patients as a Possible Marker of Acute Cellular Rejection
- Tissue miRNA profile is associated with acute tubular necrosis, rejection phenotypes and BK polyomavirus-associated nephropathy in human kidney allografts
- Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study
- Urinary Cell Gene Signature of Acute Rejection in Kidney Allografts
- Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study